| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ffa3f9d6b87e15e0a1551fb129b531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb823e72d0004ded507f810e2db46fb5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-1039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2240-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-0486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-007 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M16-14 |
| filingDate |
2014-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a5072019f2df95b6345f257326cbf41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce1ea743bb2b0a5242f264c457c88d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1040a72078cc994952c12ced2a281ec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecbc2192d8d4dd71d1d7caa806f46308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9375b451af21ab969f0d20b7ed03d31 |
| publicationDate |
2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201609206-A |
| titleOfInvention |
Improved method and system for administering pulmonary surfactant by nebulization |
| abstract |
The method and system according to a preferred embodiment of the invention optimizes the dispensing of the aerosol medicament. In particular, a system according to a preferred embodiment of the invention provides for the administration of exogenous pulmonary surfactants to very young patients, such as premature newborns. The catheter 101 delivers the aerosolized surfactant directly to the posterior pharyngeal area to increase the efficiency of administration of the agent without invasiveness: for very young patients, such as preterm neonates with neonatal respiratory distress syndrome (nRDS) Especially important. According to a preferred embodiment of the invention, the catheter is made of a biocompatible flexible material such as a plastic material. It is possible to couple the conduit to a rigid skeleton, such as a metal, to increase the stiffness of the device and to increase the ease of positioning operations. In a preferred embodiment of the invention, the delivery of the atomized medicament is carried out by means of a blower technique. |
| priorityDate |
2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |